We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$82.5B
AUM Growth
+$5.26B
(+6.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
38.94%
Holding
962
New
129
Increased
342
Reduced
292
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$429M |
| 2 |
Airbnb
ABNB
|
+$235M |
| 3 |
T-Mobile US
TMUS
|
+$156M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$139M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$488M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$222M |
| 3 |
Expeditors International
EXPD
|
+$191M |
| 4 |
Qualcomm
QCOM
|
+$187M |
| 5 |
CERN
Cerner Corp
CERN
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Consumer Discretionary | 15.99% |
| 3 | Communication Services | 13.72% |
| 4 | Healthcare | 12.84% |
| 5 | Industrials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
National Fuel Gas
NFG
$7.7B
| $124K | ﹤0.01% |
2,371
| – | – |
|
527
AGCO
AGCO
$7.03B
| $121K | ﹤0.01% |
+930
| New | +$131K |
|
528
Keysight
KEYS
$58.1B
| $117K | ﹤0.01% |
760
-261
| -26% | -$37.9K |
|
|
PCH
529
DELISTED
PotlatchDeltic
PCH
| $115K | ﹤0.01% |
+2,166
| New | +$125K |
|
530
Dover
DOV
$28.3B
| $114K | ﹤0.01% |
755
-156
| -17% | -$23K |
|
531
Sea Limited
SE
$70.1B
| $114K | ﹤0.01% |
414
| – | – |
|
|
OSH
532
DELISTED
Oak Street Health, Inc.
OSH
| $114K | ﹤0.01% |
1,944
-669
| -26% | -$39.8K |
|
533
Nucor
NUE
$62.6B
| $113K | ﹤0.01% |
1,183
-154
| -12% | -$14.4K |
|
|
MXIM
534
DELISTED
Maxim Integrated Products
MXIM
| $112K | ﹤0.01% |
1,062
-888
| -46% | -$86.9K |
|
535
Match Group
MTCH
$8.45B
| $105K | ﹤0.01% |
654
-302
| -32% | -$44.2K |
|
536
Take-Two Interactive
TTWO
$47.5B
| $103K | ﹤0.01% |
583
-200
| -26% | -$35.5K |
|
537
J. Jill
JILL
$277M
| $100K | ﹤0.01% |
+5,064
| New | +$70.1K |
|
|
SGEN
538
DELISTED
Seagen Inc. Common Stock
SGEN
| $100K | ﹤0.01% |
632
-217
| -26% | -$32.2K |
|
|
MASI
539
DELISTED
Masimo
MASI
| $97K | ﹤0.01% |
401
-138
| -26% | -$31.5K |
|
540
WIX.com
WIX
$2.55B
| $92K | ﹤0.01% |
318
-187
| -37% | -$52.4K |
|
541
Cognex
CGNX
$10.8B
| $91K | ﹤0.01% |
1,082
+157
| +17% | +$12.7K |
|
542
Ulta Beauty
ULTA
$23.9B
| $87K | ﹤0.01% |
+252
| New | +$82.6K |
|
|
SIVB
543
DELISTED
SVB Financial Group
SIVB
| $80K | ﹤0.01% |
144
+119
| +476% | +$66K |
|
|
NEE.PRP
544
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $72K | ﹤0.01% |
980
-415,236
| -100% | -$20.5M |
|
545
AbbVie
ABBV
$433B
| $66K | ﹤0.01% |
582
+123
| +27% | +$13.9K |
|
546
Prudential Financial
PRU
$42B
| $56K | ﹤0.01% |
544
-217
| -29% | -$22.2K |
|
547
iShares Russell 2000 ETF
IWM
$81.4B
| $53K | ﹤0.01% |
230
-78
| -25% | -$17.5K |
|
|
XYZ
548
Block Inc
XYZ
$47.8B
| $53K | ﹤0.01% |
218
+76
| +54% | +$17.6K |
|
549
Intel
INTC
$497B
| $52K | ﹤0.01% |
932
-23,013
| -96% | -$1.35M |
|
550
Johnson Controls International
JCI
$91.7B
| $50K | ﹤0.01% |
729
+26
| +4% | +$1.68K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2021 Portfolio in Review
As of Q2 2021, Loomis, Sayles & Company held 962 positions worth $82.5B, up 6.8% from $77.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Loomis, Sayles & Company's Q2 2021 filing shows 129 new, 342 increased, 292 reduced and 136 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 946,065 shares worth $160M. The largest sale was Deere & Co, an estimated $488M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q2 2021 buy was Alnylam Pharmaceuticals: 946,065 shares worth $160M.
- Loomis, Sayles & Company added most to Vertex Pharmaceuticals in Q2 2021, an estimated $429M increase.
- Loomis, Sayles & Company's biggest Q2 2021 reduction was Deere & Co, cutting an estimated $488M.
- Loomis, Sayles & Company fully exited Goosehead Insurance in Q2 2021, selling an estimated $66.6M.
- Loomis, Sayles & Company's ten largest holdings make up 39% of its $82.5B portfolio in Q2 2021.
- Loomis, Sayles & Company opened 129 new positions and closed 136 in Q2 2021.
- Loomis, Sayles & Company's portfolio value rose 6.8% quarter-over-quarter to $82.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2021, filed 13 Aug 2021.